These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16183647)

  • 21. Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs).
    Vazquez-Martin A; Cufí S; Oliveras-Ferraros C; Menendez JA
    Cell Cycle; 2011 Sep; 10(18):3140-52. PubMed ID: 21900751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raptor, a binding partner of target of rapamycin.
    Yonezawa K; Tokunaga C; Oshiro N; Yoshino K
    Biochem Biophys Res Commun; 2004 Jan; 313(2):437-41. PubMed ID: 14684181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Farnesylthiosalicylic acid inhibits mammalian target of rapamycin (mTOR) activity both in cells and in vitro by promoting dissociation of the mTOR-raptor complex.
    McMahon LP; Yue W; Santen RJ; Lawrence JC
    Mol Endocrinol; 2005 Jan; 19(1):175-83. PubMed ID: 15459249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
    Oshiro N; Yoshino K; Hidayat S; Tokunaga C; Hara K; Eguchi S; Avruch J; Yonezawa K
    Genes Cells; 2004 Apr; 9(4):359-66. PubMed ID: 15066126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
    Oshiro N; Takahashi R; Yoshino K; Tanimura K; Nakashima A; Eguchi S; Miyamoto T; Hara K; Takehana K; Avruch J; Kikkawa U; Yonezawa K
    J Biol Chem; 2007 Jul; 282(28):20329-39. PubMed ID: 17517883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autophagy induced by cardamonin is associated with mTORC1 inhibition in SKOV3 cells.
    Shi D; Niu P; Heng X; Chen L; Zhu Y; Zhou J
    Pharmacol Rep; 2018 Oct; 70(5):908-916. PubMed ID: 30099297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osmotic stress regulates mammalian target of rapamycin (mTOR) complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor protein phosphorylation.
    Kwak D; Choi S; Jeong H; Jang JH; Lee Y; Jeon H; Lee MN; Noh J; Cho K; Yoo JS; Hwang D; Suh PG; Ryu SH
    J Biol Chem; 2012 May; 287(22):18398-407. PubMed ID: 22493283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of mTOR pathway proteins in human amniotic fluid stem cells.
    Siegel N; Valli A; Fuchs C; Rosner M; Hengstschläger M
    Int J Mol Med; 2009 Jun; 23(6):779-84. PubMed ID: 19424604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML.
    Zeng Z; Sarbassov dos D; Samudio IJ; Yee KW; Munsell MF; Ellen Jackson C; Giles FJ; Sabatini DM; Andreeff M; Konopleva M
    Blood; 2007 Apr; 109(8):3509-12. PubMed ID: 17179228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a conserved motif required for mTOR signaling.
    Schalm SS; Blenis J
    Curr Biol; 2002 Apr; 12(8):632-9. PubMed ID: 11967149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmitate activates mTOR/p70S6K through AMPK inhibition and hypophosphorylation of raptor in skeletal muscle cells: Reversal by oleate is similar to metformin.
    Kwon B; Querfurth HW
    Biochimie; 2015 Nov; 118():141-50. PubMed ID: 26344902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning.
    Liu D; Bordicchia M; Zhang C; Fang H; Wei W; Li JL; Guilherme A; Guntur K; Czech MP; Collins S
    J Clin Invest; 2016 May; 126(5):1704-16. PubMed ID: 27018708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis.
    Shah OJ; Hunter T
    Mol Cell Biol; 2006 Sep; 26(17):6425-34. PubMed ID: 16914728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
    Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH
    Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTOR phosphorylated at S2448 binds to raptor and rictor.
    Rosner M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2010 Jan; 38(1):223-8. PubMed ID: 19145465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
    Tzatsos A; Kandror KV
    Mol Cell Biol; 2006 Jan; 26(1):63-76. PubMed ID: 16354680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.